Practical 8 : Radioligand binding assay Flashcards
what does a radioligand binding assay determine
the binding affinity between endogenous ligands and their receptors using specific radiolabelled ligands.
what can a radioligand binding assay be used for
measuring the affinity of competing ligands for a receptor- ie as a measure if how strongly a ligand binds to its receptor
in the practical you study the binding affinity of an unlabelled ligand to mAChR by testing its ability to interfere with the binding of a labelled ligand 3H-NMS. how
a competitive binding assay- vary the concentration of benzilylcholine (unlabelled ligand) while the concentration of 3H-NMS remains constant
the membrane sample, the 3H-NMS and the benzilylcholine are incubated together and are allowed to reach equilibrium. how do we separate the bound 3H-NMS from the 3H-NMS free in solution
by vacuum filtration
safe handling of radioisotopes, tritium is a low energy beta emitter, what are some guidelines for handling radioactive samples
wear protective clothing eg gloves, coats
don’t eat smoke chew
restrict work to spill tray
what is non specific binding
in addition to binding to the receptors, the 3H-NMS will also bind to other sites known as non specific sites
how can we assess non specific binding
measure conc of 3H-NMS in the presence of a saturating concentration of an unlabelled drug such as methylatropine MeAtr which occupies virtually all the receptors so H3NMS can only bind to non specific sites
how can we find the maximum number of binding sites that can be bound by the conc of 3H NMS that you use in ur assay
measure the amount of 3HNMS bound to [rotein after incubation with 1x10^9 3HNMS for 30 mins at room temp ie tube 1
how can we determine the % of specific binding of benzilylcholine at any conc to displace 2hNMS from its specific binding sites
calculating the remaining percentage specific binding ogf2HNMS eg
specific binding in presence of drug I(BCH) ie tubes 2 - 7 /
maximum specific binding ie tube 1
x 100%
what is te IC50
the molar concentration of competing ligand BCh which reduces the specific binding of a radioligand by 50% of the amount bound in the absence of competitor